retatrutide hfpef trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released phase 2 results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Looking forward to when #retatrutide's

GLP-1s changed my life. Vanessa Williams, 63 In a January 2026 cover story for Hello

Endothelial expression of fractalkine (CX3CL1) is induced by Toll-like receptor 3 signaling in cultured human glomerular endothelial cells

Ozempic is a diabetes medication that is often used off-label for weight loss

So if its been identified via a blood test (through a health professional) and your doctor recommends injections, it is important to get those B12 levels up

For treatment, dermatologically proven ingredients like Hexylresorcinol, Niacinamide, and Retinyl Propionate (HNR-3 technology) can reduce excess melanin, inhibit its transfer, and boost cell renewal, visibly improving skin tone in weeks